Most Recent
The competition regulator plans to block a group of Catholic hospital operators from collectively boycotting large private health insurers in the event funding negotiations fail.
A court has approved a $26.5 million settlement in a shareholder class action against regenerative medicine company Mesoblast.
Indian drug maker Cipla has lost a challenge to the extension of Novo Nordisk’s patent for Victoza, with a judge rejecting an argument that extensions can be granted only for active ingredients.
A class action on behalf of 700 patients alleging Monash IVF destroyed potentially viable embryos has told a court the majority of late registrants should not share in the $56 million settlement.
Construction PRO
The builders involved in Adelaide's $1.85 billion Royal Adelaide Hospital have lost their appeal of a decision blocking their bid to access documents from the state government on parliamentary privilege grounds.
The High Court has settled a 16-year battle between the federal government and Sanofi over alleged excess subsidies it paid after a judge blocked the release of a generic version of blood thinner Plavix, saying its job was not to “resurrect” a dead case.
Medical device maker Bayer has successfully defended a class action over its Essure contraceptive, with a judge finding the evidence fell short of proving the device caused chronic inflammation.
US drug company Allergan is facing a class action on behalf of women implanted with textured breast implants that were recalled after they were linked to a form of non-Hodgkin lymphoma.
Bayer has filed a High Court challenge to a decision that invalidated its patents for blockbuster blood thinner Xarelto, saying it would adversely affect drug research and development.